FOP News

ANDECAL Doses First Patient

Read more Share

Urge Your Senator to Renew the Priority Review Voucher (PRV) Program

Read more Share

UPenn's Dr. Eileen Shore Receives Prestigious Award from ASBMR

Read more Share

ICC Updates Their Statement on Off-Label Treatments

Read more Share

Regeneron's OPTIMA Phase 3 Clinical Trial is Full

Read more Share

ICC Releases 3rd Edition of the FOP Treatment Guidelines

Read more Share

Blueprint Medicines Study of BLU-782 Published in Science Translational Medicine

Read more Share

Regeneron Publishes Plain Language Summary of the LUMINA-1 Phase 2 Study in FOP

Read more Share

Andecaliximab Granted Orphan Drug Designation

Read more Share

Do You Have FOP and Have Previously Undergone Surgery to Remove Heterotopic Ossification?

Read more Share

Make a Difference

Donate Connect Fundraise

Already a Member? Sign In

Sign Up for FOP Connection, Our Monthly eNewsletter